Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple drug make shoulder surgery safer and clearer?

NCT ID NCT07686705

Disease control Sponsor: Konkuk University Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial investigates whether tranexamic acid, a drug that reduces bleeding, improves visual clarity during arthroscopic rotator cuff repair. Patients with full-thickness rotator cuff tears receive the drug either through an IV or directly into the joint, and surgeons rate how clear the view is during the procedure. The goal is to find the best way to give the drug to make surgery smoother and potentially reduce complications.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
tranexamic acid
What this could lead to
If it works, this could make rotator cuff surgery clearer and safer, potentially reducing complications and improving outcomes.
What could go wrong
This is a small, single-center trial. Tranexamic acid carries risks like allergic reactions or blood clots, and the results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

122 people

The number who actually took part.

Started

May 2022

Finished

Aug 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-80 years * Diagnosed with a rotator cuff tear * Failure of conservative treatment for more than 3 months * Rotator cuff deemed repairable on magnetic resonance imaging Exclusion Criteria: * Known hypersensitivity to tranexamic acid * Previous cerebrovascular accident * Coronary stent or other history of thromboembolic disease * Anticoagulant therapy * Uncontrolled hypertension (systolic pressure \> 180 mmHg) * Abnormal prothrombin time or activated partial thromboplastin time * Acute traumatic rotator cuff tear * Irreparable rotator cuff tear

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rotator cuff tears are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Rotator Cuff Injuries rotator cuff syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Rotator cuff tears

Contacts and locations

Locations

  • Konkuk University Medical Center

    Seoul, Seoul, 05030, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.